Investing.com - Harrow Health (NASDAQ: HROW) reported first quarter EPS of $-0.260, $0.22 worse than the analyst estimate of $-0.043. Revenue for the quarter came in at $36.36M versus the consensus estimate of $37.86M.
Harrow Health's stock price closed at $10.650. It is up 0.760% in the last 3 months and down -38.620% in the last 12 months.
Harrow Health saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Harrow Health's stock price’s past reactions to earnings here.
According to InvestingPro, Harrow Health's Financial Health score is "good performance".
Check out Harrow Health's recent earnings performance, and Harrow Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar